<?xml version="1.0" encoding="utf-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd"><url><loc>https://www.pharmamanufacturing.com/industry-news/news/55387416/c-ray-therapeutics-receives-chinas-first-radiopharma-manufacturing-license</loc><news:news><news:publication><news:name>Pharma Manufacturing</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-29T16:14:59.784Z</news:publication_date><news:title>C Ray Therapeutics receives China’s first radiopharma manufacturing license</news:title></news:news></url><url><loc>https://www.pharmamanufacturing.com/industry-news/news/55387410/vectorbuilder-maxcyte-partner-on-cell-engineering-platform-for-ex-vivo-cell-therapies</loc><news:news><news:publication><news:name>Pharma Manufacturing</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-29T16:12:06.000Z</news:publication_date><news:title>VectorBuilder, MaxCyte partner on cell engineering platform for ex vivo cell therapies</news:title></news:news></url></urlset>